)
AlzChem Group (ACT) investor relations material
AlzChem Group Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Specialty Chemicals segment drove growth, with sales up 9% and EBITDA up 16% year-over-year, offsetting declines in other segments.
Q3 sales increased 6–6.5% year-over-year, and nine-month sales rose 2–2.3% to €424.8 million.
EBITDA for nine months rose 12–12.2% to €86.2 million, with margin improving from 18.5% to 20.3%.
New creatine facility commissioned and capacity expanded, with strategic partnership with Ehrmann launching creatine-based products in supermarkets.
Outlook for 2025 confirmed, expecting record sales and EBITDA.
Financial highlights
Q3 2025 revenue: €137.3 million (+6.5% YoY); 9M 2025 revenue: €424.8 million (+2.3% YoY).
Q3 2025 EBITDA: €29.7 million (+19.5% YoY); 9M 2025 EBITDA: €86.2 million (+12.2% YoY); margin at 20.3%.
Net income for nine months rose 20% to €46.8 million; EPS up to €4.62.
Operating cash flow for nine months increased to €115.5 million (+53.8% YoY).
Free cash flow remained strong at €48.1 million despite record capital expenditure.
Outlook and guidance
2025 sales forecast: approximately €580 million; EBITDA forecast: at least €113–130 million.
Growth expected mainly from Specialty Chemicals, especially Creapure®, Creamino®, and Nitroguanidin.
Basics & Intermediates segment expected to see slight sales decline due to steel industry weakness.
No material negative impact expected from US tariffs; further US dollar weakening could affect results.
Inventory intensity and equity ratio expected to remain stable.
- TimeTickerHeadlineOpen
- DANSKE
Record core income and strong credit quality drove DKK 23.0bn net profit; 2026 outlook positive. - DANSKE
Record core income, strong credit quality, and 100% profit distribution define 2025 results. - 7211
Net sales and profits fell year-over-year, but recent earnings show gradual recovery. - 524742
Strong revenue and profit growth with robust margins and expanding global presence in Q3 FY26. - ANTHEM
Q3 FY26 saw robust revenue, profit growth, and capital increase post-IPO and ESOP allotments. - AFRY
Margin and utilization gains in Q4 offset lower sales and profit amid market challenges. - 8111
Sales and operating profit rose, but net profit fell on lower affiliate gains; outlook steady. - 7731
Large impairment in Digital Manufacturing and weak sales led to sharp losses and a weaker outlook. - 6370
Profits and sales rose, led by General Industry, with robust capital actions and a positive outlook. - 9312
Profits and dividends rose on strong domestic logistics, with improved financial stability.
Next AlzChem Group earnings date
Next AlzChem Group earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)